Related Experiment Video
Updated: Aug 17, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in
James R Shoblock1, Nigel T Maidment
1Department of Psychiatry and Biobehavioral Science, University of California Los Angeles, Los Angeles, CA 90024, USA. shoblock@ucla.edu
Abstract:
Naloxone administration produces a robust conditioned place aversion (CPA) in opiate-naive rodents by blocking the action of enkephalins at mu opioid receptors. This aversive response is potentiated by prior exposure to morphine. In vitro studies indicate that morphine treatment may promote constitutive activity of mu opioid receptors. We hypothesized that such enhanced constitutive activity in vivo may underlie the increased aversive property of naloxone by uncovering the inverse agonist property of this drug. The CPA produced by naloxone was compared with that produced by the neutral antagonists 6-alpha- and 6-beta-naloxol in mice with and without prior morphine exposure. While all three drugs produced CPA, only naloxone CPA was enhanced by morphine given 20 h prior to each naloxone injection. Furthermore, only naloxone produced withdrawal jumping when given 20 h after morphine, even though 6-alpha-naloxol was able to produce jumping when given 4 h after morphine. These data suggest that morphine may enhance naloxone CPA by increasing levels of constitutively active mu receptors and further support the role of such constitutive activity in mediating naloxone-precipitated physical withdrawal. Such long-term changes in constitutive activity of the mu receptor induced by exogenous opiate exposure may thus be an important factor in hedonic homeostatic dysregulation proposed to underlie the addictive process.
Insights
Morphine exposure enhances naloxone
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Naloxone causes aversion in rodents by blocking mu opioid receptors.
- Morphine pre-exposure potentiates this naloxone-induced aversion.
- Morphine may increase constitutive activity of mu opioid receptors.
Purpose of the Study:
- To investigate if enhanced mu opioid receptor constitutive activity underlies naloxone's potentiated aversion after morphine exposure.
- To compare naloxone's effects with neutral antagonists (6-alpha- and 6-beta-naloxol) in mice with and without prior morphine exposure.
Main Methods:
- Conditioned Place Aversion (CPA) testing in mice.
- Administration of naloxone, 6-alpha-naloxol, and 6-beta-naloxol.
- Prior morphine exposure at varying intervals before antagonist administration.
Main Results:
- All tested drugs produced CPA.
- Morphine pre-exposure selectively enhanced naloxone-induced CPA.
- Only naloxone precipitated withdrawal jumping at 20 hours post-morphine, unlike 6-alpha-naloxol at 4 hours.
Conclusions:
- Morphine enhances naloxone's aversive effects by increasing constitutively active mu opioid receptors.
- Constitutive mu opioid receptor activity plays a role in naloxone-precipitated withdrawal.
- Long-term changes in mu receptor activity from opiate exposure may contribute to addiction-related dysregulation.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Abuse and Addiction: Pharmacological Phenomena
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...

